Boppli Non-Invasive Blood Pressure Device for Newborns
Summary
This registry entry documents observational study NCT07547917, which evaluates the Boppli non-invasive blood pressure device in newborn infants within a neonatal intensive care unit setting. The study compares continuous Boppli measurements against standard cuff-based blood pressure readings and includes a follow-up component extending through 1 year of age to assess longer-term outcomes. Conditions under study include neonatal hypertension and the intervention is the Boppli device itself.
“This study evaluates a new, non-invasive device (Boppli™) that continuously measures blood pressure in newborn infants.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This entry registers a new observational clinical study, NCT07547917, on ClinicalTrials.gov. The study aims to validate Boppli, a non-invasive continuous blood pressure monitoring device, by comparing its readings to standard cuff measurements in newborn infants in the NICU. It also tracks follow-up outcomes through 1 year of age. This is a registry entry and does not establish new regulatory obligations or compliance requirements. Healthcare providers, clinical investigators, and medical device manufacturers involved in neonatal monitoring technologies may wish to track study findings for implications on device adoption.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Measurement of High Blood Pressure Using Boppli
Observational NCT07547917 Kind: OBSERVATIONAL Apr 23, 2026
Abstract
This study evaluates a new, non-invasive device (Boppli™) that continuously measures blood pressure in newborn infants. The study compares Boppli measurements to standard blood pressure cuff measurements to determine how well the device works and whether it improves identification of high blood pressure in infants in the neonatal intensive care unit (NICU). The study also includes follow-up through 1 year of age to understand longer-term outcomes.
Conditions: Hypertension, Neonatal
Interventions: Boppli
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.